All the information you need about BIOTECH DEVELOPPEMENT SILAB - JEAN PAUFIQUE to develop and secure your business in France

| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2022-08-12 | Public | 2021-12-31 | Simplified |
| 2021-06-23 | Public | 2020-12-31 | Complete |
| 2017-07-21 | Public | 2016-12-31 | Complete |
| Name | BIOTECH DEVELOPPEMENT SILAB - JEAN PAUFIQUE |
| Siren | 798773321 |
| Closing | 2021-12-31 |
| Registry code | 1901 |
| Registration number | 2786 |
| Management number | 2013B00467 |
| Activity code | 6612Z |
| Closing date n-1 | 2020-12-31 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 12 |
| Filing date | 2022-08-12 |
| Modification | 00 Annual accounts entered without anomaly |
| Balance sheet type | S : Simplified |
| Currency code | EUR |
| Confidentiality | Public |
| Address | 19130 Objat |
| 1 - Assets and liabilities (balance sheet) | Gross amount N | Amortization year N | Net year N | Net year N-1 |
040 Financial Assets | 240 000.00 | 240 000.00 | 240 000.00 | |
044 Total Fixed Assets | 240 000.00 | 240 000.00 | 240 000.00 | |
084 Cash | 142 103.00 | 142 103.00 | 142 103.00 | |
096 Total Current Assets + Prepaid Expenses | 142 103.00 | 142 103.00 | 142 103.00 | |
110 Total Assets | 382 103.00 | 382 103.00 | 382 103.00 | |
120 Share or Individual Capital | 200 000.00 | |||
134 Retained Earnings | -58 080.00 | |||
136 Profit for the Year | -12 634.00 | |||
142 Total Equity - Total I | 129 286.00 | |||
166 Suppliers and related accounts | 7 132.00 | |||
169 Other debts including current accounts of partners for fiscal year N | 245 685.00 | |||
172 Other debts | 245 685.00 | |||
176 Total debts | 252 817.00 | |||
180 Liabilities Total | 382 103.00 | |||
184 Selling price excluding VAT of fixed assets sold during the financial year | 4 000.00 | |||
| 2 - Income statement | Amount year N | Amount year N-1 | ||
242 Other external expenses | 9 822.00 | 9 822.00 | ||
264 Total operating expenses | 9 822.00 | 9 822.00 | ||
270 Operating profit | -9 822.00 | -9 822.00 | ||
280 Financial income | 16 000.00 | 16 000.00 | ||
290 Exceptional income | 4 000.00 | 4 000.00 | ||
294 Financial expenses | 2 813.00 | 2 813.00 | ||
300 Exceptional expenses | 20 000.00 | 20 000.00 | ||
310 Profit or loss | -12 634.00 | -12 634.00 | ||
| 3 - Fixed assets - Depreciation - Capital gains, Capital losses | Amount for year N | |||
484 DECREASES Financial Assets | 20 000.00 | 20 000.00 | ||
490 Total Fixed Assets (Gross Value) | 260 000.00 | 260 000.00 | ||
494 Total Fixed Assets (Decreases) | 20 000.00 | 20 000.00 | ||
582 Total Capital Gains, Capital Losses (Residual Value) | 20 000.00 | 20 000.00 | ||
584 Total Capital Gains, Capital Losses (Sale Price) | 4 000.00 | 4 000.00 | ||
596 Total Fixed Assets – Depreciation – Capital Gains, Capital Losses (Short Term) | -16 000.00 | -16 000.00 | ||
| 4 - Relevé des Provisions - Amortissements dérogatoires - Déficits reportables | Amount for year N | |||
634 DECREASES Provisions for Depreciation – On Fixed Assets | 16 000.00 | 16 000.00 | ||
684 DECREASES in Total Provisions Statement | 16 000.00 | 16 000.00 | ||
